MML Investors Services’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
57,365
+22,629
+65% +$508K ﹤0.01% 1846
2026
Q1
$784K Buy
34,736
+10,072
+41% +$231K ﹤0.01% 1932
2025
Q4
$588K Buy
24,664
+3,900
+19% +$97K ﹤0.01% 2147
2025
Q3
$547K Sell
20,764
-2,147
-9% -$55.2K ﹤0.01% 2110
2025
Q2
$655K Buy
22,911
+4,859
+27% +$130K ﹤0.01% 1921
2025
Q1
$449K Buy
18,052
+1,238
+7% +$29.5K ﹤0.01% 2054
2024
Q4
$381K Buy
16,814
+1,795
+12% +$39K ﹤0.01% 2106
2024
Q3
$320K Buy
15,019
+753
+5% +$14.8K ﹤0.01% 2133
2024
Q2
$272K Buy
14,266
+293
+2% +$5.97K ﹤0.01% 2149
2024
Q1
$269K Buy
13,973
+2,916
+26% +$57.8K ﹤0.01% 2182
2023
Q4
$230K Buy
+11,057
New +$212K ﹤0.01% 2227
2018
Q4
– Sell
-4,972
Closed -$256K – 1534
2018
Q3
$256K Buy
+4,972
New +$249K ﹤0.01% 1353
2017
Q4
– Sell
-8,170
Closed -$399K – 1412
2017
Q3
$399K Buy
8,170
+962
+13% +$45.7K 0.01% 881
2017
Q2
$348K Buy
7,208
+748
+12% +$34.4K 0.01% 910
2017
Q1
$272K Buy
+6,460
New +$267K 0.01% 630

Other funds holding FMS

MML Investors Services's FMS Position: Q2 2026 in Review

MML Investors Services increased its Fresenius Medical Care (FMS) stake by 65% in Q2 2026, buying an estimated $508K and bringing the position to 57,365 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1846.

MML Investors Services first reported a position in FMS in Q1 2017 and has held it in 15 quarters since. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • MML Investors Services held 57,365 shares of Fresenius Medical Care worth $1.3M as of Q2 2026.
  • MML Investors Services bought 22,629 Fresenius Medical Care shares in Q2 2026, an estimated $508K.
  • Fresenius Medical Care made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #1846 holding.
  • MML Investors Services first reported a position in Fresenius Medical Care in Q1 2017 and has held it in 15 quarters since.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.